Mkts

Gossamer Bio, Inc.

NASDAQ: GOSS
$10.38-0.31 (-2.90%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
10.1710.75
52-week range
8.29309.60
Today
Open10.56
Previous close10.38
Volume179.3K
Valuation
Market cap63.43M
P/E ratio—
EPS (TTM)-0.56
Income & risk
Dividend / yield—
Beta2.29
Avg volume330.2K
Discussion

GOSS News

Stories mentioning GOSS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue16,95513,79913,29411,4899,8899,3799,48095,842
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses61,82159,83862,40850,25446,69945,50743,39943,755
Operating Income (Loss)(44,866)(46,039)(49,114)(38,765)(36,810)(36,128)(33,919)52,087
Interest Income354.00447.00687.00542.00294.00(744.00)430.001,749
Interest Expense
Other Expense603.001,0172,9542,6942,6244,1714,2882,747
Pretax Income(48,221)(38,273)(31,935)53,667
Tax Provision0.000.00(1,132)4,435
Net Income (Loss)(46,664)(47,238)(48,221)(38,273)(36,638)(33,029)(30,803)49,232
Earnings Per Share (Basic)(0.20)(0.21)(0.21)(0.17)(0.16)(0.15)(0.14)0.22
Earnings Per Share (Diluted)(0.20)(0.21)(0.21)(0.17)(0.16)(0.15)(0.14)0.22
Weighted Average Shares Outstanding (Basic)234,137228,519227,981227,275226,818226,228226,346226,221
Weighted Average Shares Outstanding (Diluted)234,137228,519227,981227,275226,818226,228226,346238,543

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About GOSS

Gossamer Bio, Inc. (NASDAQ: GOSS) is a stock listed on the Nasdaq Stock Market under the ticker symbol GOSS. It last traded at $10.38 (Oct 30, 2026, 4:00 PM ET), down 2.9% on the day. That gives Gossamer Bio a market capitalisation of $63.4M.

Over the past 52 weeks GOSS has traded between $8.29 and $309.60.

Revenue for the quarter ended Mar 31, 2026 was $17.0M; a net loss of $46.7M. Revenue was up 71.5% from $9.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$17.0M-$46.7M-275.2%
Dec 31, 2025$13.8M-$47.2M-342.3%
Sep 30, 2025$13.3M-$48.2M-362.7%
Jun 30, 2025$11.5M-$38.3M-333.1%

From Gossamer Bio’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…